Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-21

FDA Approved: TOPIRAMATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves a supplemental application to add a Topiramate Sprinkle formulation, expanding the available dosage form for topiramate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate Sprinkle (Topiramate)

Snippet

SUPPL AP for TOPIRAMATE (TOPIRAMATE SPINKLE)